London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
'In summary, the early use of aspirin in covid-19 patients, which has the effects of inhibiting virus replication, anti-platelet aggregation, anti-inflammatory and anti-lung injury, is expected to reduce the incidence of severe and critical patients, shorten the length of hospital duration and reduce the incidence of cardiovascular complications.'
https://clinicaltrials.gov/ct2/show/NCT04365309
behind curve in terms of news,yes,but action....? Time will tell.
What a product not to be potentially contributing!
We can all agree that the BB has woken up at long last. I responded to the monthly FF newsletter and I have also contacted the Company. In both cases, politely pointing out that we should be advertising what we have. No response, but perhaps some activity behind closed doors. We do have a very clever scientist on the BOD. I would like to believe that she is fully aware of the situation. If nothing comes of this, we really are way behind the curve.
Surely we have a product in fruitflow that could be very useful. Read the link.
https://www.bbc.co.uk/news/health-52662065
Well, they would certainly be able to release an RNS in light of chat board speculation, and they'd be able to quote the patents regarding platelet aggregation. Not denying that, just saying that there could be other forms of aggregation against which nothing is proven. We'll see, but undeniably the can of worms is open now.
Good post DD77. AVACTA is a company which believes whole heartedly in what could potentailly be its world beating product.
It has a hugely impressive tactically astute CEO and isn't letting itself be ignored by the naturally conservative (at least till Covid) pharma majors.
its not against market rules to speculate alfista as long as the RNS makes it clear what is speculated (or to use the term in this weeks IMM RNS postulated).
In any event it is not speculation to refer to the very recent research tending to show that spiky platelets can cause critical blood clots in a substantial number of Covid patients. And regular consumption of fruitflow deals with spiky platelets.
Get in into an RNS and then if any dots still need to be joined DSM donate one weeks pocket money.
It isn't a medicine. We don't need phases one two and three.
Of course they can, loads of companies do. Avacta who i'm also invested in put one out yesterday on potentially being able to prevent covid 19
****************************/articles/avacta-group-finds-significant-potential-for-covid-19-therapy-13dd970/
apols-broke to watch. Fasinating as disturbing.
PXS alone ,or hand in hand alongside DSM should be working fast to further research.
My feel is they are. And potential here could be the gem in their portfolio.
BBC News right NOW -Sticky platelets!
Dead wrong.
A company can't put out anything speculative such as that. Against market rules.
All you want is a stampede to get out on.
Any number of genuine reasons are feasible, none of them being you cynical view.
We know that studies take a long time, and, if they are clinical, would require the recruitment of volunteers against a backdrop of loads of other studies, some funded by big pharma.
Totally unrealistic
So, release an RNS saying they believe FF+ has potential benefits for covid symptoms which they are keen to investigate further............it's not difficult. There are only 2 reasons why they would not - they either do not believe in the product or they just can't be bothered with the effort
Amazing that IF must of had in the region of ( Incl share options ) £2 mill out of PXS.
can aggregate inside blood vessels and potentially cause blood clots.
That is trite. DSM literature says so. It needs no further proof.
The PXS boards communication level is dire. We haven't had a clue on their thinking in years. The chairmans annual statement imo might as well be a copy and paste excercise.
They can't be bothered being proactive imo. Moon had no vision for the product and neither it appears has his succesors. They have offloaded it to the "experts" who don't particularly need fruitflow to do well.
Nothing imo will change here because shareholders have either sold up like me or live in hope like some on here(good luck) or they've had the stuffing knocked out of them.
Potential yes.
Proven?
Adding one and one and getting ten thousand is not something a company can do, despite hopeful punters longing for it.
I hope they do jump on the bandwagon, just so i can get out of this share with some semblence of a return. The 6 month blackout on information is scandalous, particularly in mind of the potential benefits FF could bring.
I'm in agreement with you that Fruitflow should be studied, and sure that the scientists would have been all over the news that Covid has drastic effects on blood vessels. How much further they could take it is questionable, since the media suggest that the research is being carried out at high security centres such as Porton Down. Eyes will be watching Dr Asim's social media for any observations, and I don't doubt that brands with existing or potential Fruitflow versions will be asking questions of the technical team.
Time will tell, I know you want faster action than that, it would be a shame if the information was published after the crisis is over, but I have a strong feeling that it will be.
Wow Alf..Harsh. To my understanding no-one has attempted to ramp with uninformed hype.(ditto 1st line W$).
Just genuine questions being raised in relation to the proven facts we already know about FFs credentials.
Surely its obvious that any further properties FF could potentially offer,Covid (in this instance)or otherwise,should be fully explored .
Speculation is not good but discussion should be welcome here,as would be more communication from the CEO
to inform shareholders if further research will be/is being carried out.
Appreciating all the posts.
Alf - no one is advocating profiting from uninformed hype.
The truth is we have spent over 10 years developing a product to help with blood flow with no side effects, and now the world needs such a product. We have heard absolutely nothing, since the out break. I read somewhere there are currently over 300 clinical trials worldwide looking into all sorts of ways of combating the virus. If FF isn’t being evaluated then PXS/DSM have missed a golden opportunity. I believe, maybe naively, FF is being evaluated and I am expecting an update some time.
BTW, an interesting article from BHF.
https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/behind-the-headlines/coronavirus/coronavirus-and-bame-patients?utm_campaign=1410018_HeartMatters_enewsletter_NonHCP2_May2020_2&utm_medium=email&utm_source=British%20Heart%20Foundation%20%28BHF%29%20&mi_u=8-18884270
W$
What do we know?
The health claims patented for Fruitflow have specific reference to smoothing aggravated platelets. Do we know if the "sticky blood" issue associated with Covid is caused by this type of inflammation. I don't, and am not a clinician, so have to consider that it may be caused by something else. The research on high activity sports people suggests that Fruitflow is effective, but I don't think anyone should start claiming it as a cure, because cures are for products that have undergone far more, NICE approved, billion pound budget, trials such as those carried out by drug companies.
I'd urge caution. The last thing the brand needs is to be dismissed as a quack remedy for Covid, that would be disastrous. I'm absolutely certain that studies will be made, and results published. Of course I want Fruitflow sales to advance, but, on reflection, I disagree with the greed driven, uninformed hype. Proof is essential, and it is something we don't have in relation to Covid.
Sphinx
been waiting for a familiar face to report (bbc)
Let’s see if our facebook page reports it and recommends FF.
W$
Up to 30% of patients who are seriously ill with coronavirus are developing dangerous blood clots, according to medical experts.
They say the clots, also known as thrombosis, could be contributing to the number of people dying. Fruiflow to the rescue, one hopes.
Coronavirus: A third of hospital patients develop dangerous blood clots https://www.bbc.co.uk/news/health-52662065
Shhhhhhhhhh
Why are they not all over this,promoting fruitflow